| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/18/2002 | WO2002035228A3 Method and test kit for detecting analytes in a sample |
| 07/18/2002 | WO2002034280A3 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain |
| 07/18/2002 | WO2002031485B1 Acid gas measuring sensors and method of making same |
| 07/18/2002 | WO2002031025A3 Biodegradable poly(beta-amino esters) and uses thereof |
| 07/18/2002 | WO2002029402A3 System for electrophysiological measurements |
| 07/18/2002 | WO2002029088A3 Highly expressible genes |
| 07/18/2002 | WO2002029003A3 Massive parallel method for decoding dna and rna |
| 07/18/2002 | WO2002028414B1 Compositions and methods for wt1 specific immunotherapy |
| 07/18/2002 | WO2002028351A3 Recombinant mucin binding proteins from steptococcus pneumoniae |
| 07/18/2002 | WO2002027322A3 Reagents, method and kit for detecting phosphinothricin-n-acetyltransferase protein |
| 07/18/2002 | WO2002023165A3 Apparatus for non-destructively testing material |
| 07/18/2002 | WO2002022855A3 Test-strips with positively charged membranes for tetrazolium based assays |
| 07/18/2002 | WO2002022264A8 Method and apparatus for gradient generation |
| 07/18/2002 | WO2002019894A3 Methods for analyzing and using data from hypertensive patients |
| 07/18/2002 | WO2002016310A9 Selective androgen receptor modulators and methods of use thereof |
| 07/18/2002 | WO2002014533A3 Creatinine sensor calibration |
| 07/18/2002 | WO2002007722A3 Valproic acid and derivatives thereof as histone deacetylase inhibitors |
| 07/18/2002 | WO2002006834A9 Nested sorting and high throughput screening |
| 07/18/2002 | WO2002006517A9 High-throughput methods for generating and screening compounds that affect cell viability |
| 07/18/2002 | WO2002006311A3 Olfactory g-protein coupled receptor |
| 07/18/2002 | WO2002006242A3 5-substituted 2-aryl-4-pyrimidinones |
| 07/18/2002 | WO2002004923A3 Repeated impact apparatus and method for characterizing granule strength |
| 07/18/2002 | WO2002002633A3 Transporters and ion channels |
| 07/18/2002 | WO2002002557A3 2-phenylimidazo[1,2-a]pyridine derivatives: a new class of gaba brain receptor ligands |
| 07/18/2002 | WO2002000927A3 Diagnosis of diseases associated with development by means of assessing their methylation status |
| 07/18/2002 | WO2002000926A8 Diagnosis of diseases associated with signal transduction |
| 07/18/2002 | WO2001096862A3 Method for increasing luminescence assay sensitivity |
| 07/18/2002 | WO2001096834B1 Biosensor and deposit sensor for monitoring biofilm and other deposits |
| 07/18/2002 | WO2001094951A3 Inhibitors of c-reactive protein induced inflammation |
| 07/18/2002 | WO2001094391A3 Intracellular signaling proteins |
| 07/18/2002 | WO2001090328A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/18/2002 | WO2001087980A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 07/18/2002 | WO2001086265A3 H02 doped w03, ultra-fast, high-sensitive hydrogen sensors |
| 07/18/2002 | WO2001085798A3 Human monoclonal antibodies to dendritic cells |
| 07/18/2002 | WO2001084149A3 Diagnostics and therapeutics for macular degeneration-related disorders |
| 07/18/2002 | WO2001083749A3 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners |
| 07/18/2002 | WO2001083518A3 Molecules that modulate ubiquitin-dependent proteolysis and methods for identifying same |
| 07/18/2002 | WO2001081590A3 Protein phosphatases |
| 07/18/2002 | WO2001081544A3 Identification and uses of a hyaluronan receptor |
| 07/18/2002 | WO2001081408A3 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 07/18/2002 | WO2001079468A3 Drug metabolizing enzymes |
| 07/18/2002 | WO2001079282A3 Molecules associated with human reproduction |
| 07/18/2002 | WO2001077664A3 Molecularly imprinted polymeric sensor for the detection of explosives |
| 07/18/2002 | WO2001077072A3 Compounds and methods to increase plasma hdl cholesterol levels and improve hdl functionality |
| 07/18/2002 | WO2001073395A3 Method of preventing short sampling of a capillary or wicking fill device |
| 07/18/2002 | WO2001073117A9 Use of particles which have signal-emitting characteristics and at least one group with an affinity for marked nucleic acids |
| 07/18/2002 | WO2001072822A3 Genes involved in intestinal inflammatory diseases and use thereof |
| 07/18/2002 | WO2001071359A3 Methods for identifying and isolating tissue-specific lumen-exposed molecules |
| 07/18/2002 | WO2001071041A3 Microarray-based analysis of polynucleotide sequence variations |
| 07/18/2002 | WO2001068839A9 Regulation of human lipoxin a4 receptor-like protein |
| 07/18/2002 | WO2001068705A3 Il-17 receptor like molecules and uses thereof |
| 07/18/2002 | WO2001067087A3 Fluid handling devices with diamond-like films |
| 07/18/2002 | WO2001066747A3 Proteins named fctrx and nucleic acids encoding same |
| 07/18/2002 | WO2001061358A9 A method of assessing the biological status of pathology in epithelial tissue, especially colon |
| 07/18/2002 | WO2001060400B1 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease |
| 07/18/2002 | WO2001059452A3 Method for diagnosing efficacy of xenotypic antibody therapy |
| 07/18/2002 | WO2001058461A9 Mycobacterium ag85 complex-specific t cell peptides and use in diagnostic and therapeutic applications thereof |
| 07/18/2002 | WO2001057269A3 Nucleic acid detection methods using universal priming |
| 07/18/2002 | WO2001055366A9 T cell receptor libraries |
| 07/18/2002 | WO2001052614A9 Selecting and producing t cell peptide epitopes |
| 07/18/2002 | WO2001051667A3 Informative nucleic acid arrays and methods for making same |
| 07/18/2002 | WO2001051520A9 Nogo receptor-mediated blockade of axonal growth |
| 07/18/2002 | WO2001044501A3 Method and device for detecting and quantifying biomolecules |
| 07/18/2002 | WO2001040503A3 Method for identification and quantification of kinase inhibitors |
| 07/18/2002 | WO2001040310A3 Immobilisation of proteins using a polypeptide segment |
| 07/18/2002 | WO2001039766A3 Screening invertebrate pheromones for therapeutic activity |
| 07/18/2002 | WO2000078972A9 Regulation with binding cassette transporter protein abc1 |
| 07/18/2002 | US20020095262 Method of non-intrusively monitoring the mixture ratio of a gas mixture having at least two components |
| 07/18/2002 | US20020095260 Methods for efficiently mining broad data sets for biological markers |
| 07/18/2002 | US20020095258 System and methods for optimized drug delivery and progression of diseased and normal cells |
| 07/18/2002 | US20020095073 Clinically intelligent diagnostic devices and mehtods |
| 07/18/2002 | US20020095027 Polypeptide for use in the diagnosis and treatment of viral diseases in animals |
| 07/18/2002 | US20020095024 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 07/18/2002 | US20020094995 Modification of the molecular structure of dihydropyridine family drug containing one or more hydrogen atoms by deuterating one or more hydrogen atoms to deuterium atoms; improved activity over the known drug |
| 07/18/2002 | US20020094957 Inhibits the polymerization of amyloid beta peptide; treating or preventing amyloidosis |
| 07/18/2002 | US20020094955 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 07/18/2002 | US20020094954 Nucleic acids comprising the neuregulin-1-associated gene 1 (NRG1AG1) |
| 07/18/2002 | US20020094947 By administering with the excitatory opioid receptor antagonist nalmefene |
| 07/18/2002 | US20020094586 Detection of analytes |
| 07/18/2002 | US20020094585 Apparatus for use in the detection of preferential particles in sample |
| 07/18/2002 | US20020094584 Microfluidic apparatus for use in determining sequence of biopolymers |
| 07/18/2002 | US20020094583 Apparatus for use in medical evaluation of fluid samples and diagnosis human defects |
| 07/18/2002 | US20020094577 Cytological and histological fixative composition and methods of use |
| 07/18/2002 | US20020094566 Integrated high throughput system for the mass spectrometry of biomolecules |
| 07/18/2002 | US20020094561 Peptide; for use in the treatment of tumors, metabolic and autoimmune disease |
| 07/18/2002 | US20020094559 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of cardiovascular disorders |
| 07/18/2002 | US20020094557 Enzymatic polypeptide for use in the generation of terpenes |
| 07/18/2002 | US20020094556 Enzymatic polypeptide for use in generation of preferential terpenes |
| 07/18/2002 | US20020094551 T2R taste receptors and genes ecncoding same |
| 07/18/2002 | US20020094550 Generating cells for grafting; obtain erythrocytes, lysis, monitor leukocyte signal, determine conentration of leukocytes |
| 07/18/2002 | US20020094549 Screening methods for presqualene diphosphate analogs |
| 07/18/2002 | US20020094548 Systems and methods for performing magnetic chromatography assays |
| 07/18/2002 | US20020094547 Differential diagnosis of cancer and other conditions based on expression of p63 |
| 07/18/2002 | US20020094546 Detecting platelet derived growth factor in sample; obtain sample, incubate with preferential binding agent, detect bound antigen |
| 07/18/2002 | US20020094544 Solid support for use as analytical tool in genetic analysis |
| 07/18/2002 | US20020094543 Support and method for cell based assays |
| 07/18/2002 | US20020094541 Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof |
| 07/18/2002 | US20020094540 N-TRADD active site and uses thereof |
| 07/18/2002 | US20020094539 Methods and reagents for analysis of RNA structure and function |
| 07/18/2002 | US20020094537 Device and method for tracking conditions in an assay |